Dr. Schrag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic Neurol
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Summary
- I run a specialty clinic focusing on cerebral amyloid angiopathy and other microvascular diseases of the brain including CADASIL, Binswanger's disease, COL4a1-vasculopathy, infectious angiopathy and RCVS. My research laboratory focuses on understanding the neurobiology of vascular fragility in cerebral amyloid angiopathy.
Education & Training
Yale-New Haven Medical CenterResidency, Neurology, 2012 - 2015- Yale-New Haven Medical CenterInternship, Internal Medicine, 2011 - 2012
Loma Linda University School of MedicineClass of 2011
Certifications & Licensure
TN State Medical License 2015 - 2026
KY State Medical License 2017 - 2025- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Publications & Presentations
PubMed
- Atrial Fibrillation and Retinal Stroke.Jay B Lusk, Vinit Nalawade, Lauren E Wilson, Ailin Song, Matthew Schrag
JAMA Network Open. 2025-01-02 - A Streamlined Workflow for Microscopy-Driven MALDI Imaging Mass Spectrometry Data Collection.Allison B Esselman, Megan S Ward, Cody R Marshall, Ellie L Pingry, Martin Dufresne
Journal of the American Society for Mass Spectrometry. 2024-12-04 - Basic Science and Pathogenesis.Yongchao Wang, Wilber Romero Fernandez, Cristian O Carvajal-Tapia, Alena Shostak, Paige Rieschick
Alzheimer's & Dementia. 2024-12-01
Journal Articles
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer DiseaseHyun-Sik Yang, Reisa Sperling, Matthew Schrag, Richard Mayeux, JAMA Neurology
Authored Content
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer DiseaseJune 2020
Press Mentions
What Drugmakers Did Not Tell Volunteers in Alzheimer’s TrialsOctober 23rd, 2024- New Schizophrenia Treatment; The Increase in Stroke Incidence; TikTok Claims About Mucinex and Pregnancy; Plus Other News Stories with VUMC SourcesOctober 9th, 2024
- The New Alzheimer’s Disease Test You Should Know AboutAugust 6th, 2024
- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
